{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:24:26Z","timestamp":1785367466625,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tokai University, Shonan Campus"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12928-026-01297-9","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:30:06Z","timestamp":1779557406000},"page":"680-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Histology-validated comparison of angioscopy, IVUS, and OFDI for assessing stent strut coverage in femoropopliteal arteries with thin neointima"],"prefix":"10.1007","volume":"41","author":[{"given":"Kazuki","family":"Aihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-0427","authenticated-orcid":false,"given":"Sho","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaho","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Ohmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Shiozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"7","key":"1297_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjpc\/zwad381","volume":"31","author":"C Adou","year":"2024","unstructured":"Adou C, Magne J, Gazere N, Aouida M, Chastaingt L, Aboyans V. Global epidemiology of lower extremity artery disease in the 21st century (2000-21): a systematic review and meta-analysis. Eur J Prev Cardiol. 2024;31(7):803\u201311.","journal-title":"Eur J Prev Cardiol"},{"issue":"36","key":"1297_CR2","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700.","journal-title":"Eur Heart J"},{"key":"1297_CR3","doi-asserted-by":"crossref","unstructured":"Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Lori Byrd VC, ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease. J Am Coll Cardiol. 2024;18;83(24):2497\u2009\u2013\u2009604.","DOI":"10.1016\/j.jacc.2024.02.013"},{"issue":"6","key":"1297_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41569-018-0005-0","volume":"15","author":"JS Hiramoto","year":"2018","unstructured":"Hiramoto JS, Teraa M, de Borst GJ, Conte MS. Interventions for lower extremity peripheral artery disease. Nat Rev Cardiol. 2018;15(6):332\u201350.","journal-title":"Nat Rev Cardiol"},{"issue":"10190","key":"1297_CR5","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/S0140-6736(19)30474-X","volume":"393","author":"R Piccolo","year":"2019","unstructured":"Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019;393(10190):2503\u201310.","journal-title":"Lancet"},{"issue":"4","key":"1297_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jvs.2013.10.050","volume":"59","author":"T Dohi","year":"2014","unstructured":"Dohi T, Iida O, Soga Y, Hirano K, Suzuki K, Takahara M, et al. Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions. J Vasc Surg. 2014;59(4):1009\u2013e151.","journal-title":"J Vasc Surg"},{"issue":"6","key":"1297_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","volume":"15","author":"O Iida","year":"2022","unstructured":"Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. 1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration. JACC Cardiovasc Interv. 2022;15(6):630\u20138.","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"1297_CR8","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115(18):2435\u201341.","journal-title":"Circulation"},{"issue":"11","key":"1297_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","volume":"136","author":"T Adriaenssens","year":"2017","unstructured":"Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, et al. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort). Circulation. 2017;136(11):1007\u201321.","journal-title":"Circulation"},{"issue":"1","key":"1297_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","volume":"17","author":"S Torii","year":"2020","unstructured":"Torii S, Jinnouchi H, Sakamoto A, Kutyna M, Cornelissen A, Kuntz S, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol. 2020;17(1):37\u201351.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1297_CR11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jcin.2019.10.060","volume":"13","author":"SH Kuntz","year":"2020","unstructured":"Kuntz SH, Torii S, Jinnouchi H, Cornelissen A, Sakamoto A, Sato Y, et al. Pathology and Multimodality Imaging of Acute and Chronic Femoral Stenting in Humans. JACC Cardiovasc Interv. 2020;13(4):418\u201327.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"1297_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1253\/circj.CJ-21-0984","volume":"86","author":"Y Matsumoto","year":"2022","unstructured":"Matsumoto Y, Torii S, Morino Y. Pathography of Superficial Femoral Artery Treated With ELUVIA(TM) Paclitaxel Eluting Stent. Circ J. 2022;86(6):1021.","journal-title":"Circ J"},{"key":"1297_CR13","doi-asserted-by":"crossref","unstructured":"Hata Y, Iida O, Torii S, Shiozaki M, Mano T. Five-year Histological Evaluation of Paclitaxel-eluting stent for an Infrapopliteal Lesion: A Case Report. Eur Heart J - Case Rep. 2026:ytag061.","DOI":"10.1093\/ehjcr\/ytag061"},{"issue":"11","key":"1297_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1253\/circj.CJ-20-0551","volume":"84","author":"T Tsujimura","year":"2020","unstructured":"Tsujimura T, Ishihara T, Iida O, Hata Y, Kurata N, Asai M, et al. Angioscopic Assessments at 3 Months After Fluoropolymer-Based Paclitaxel-Eluting Stent Implantation for Femoropopliteal Endovascular Intervention. Circ J. 2020;84(11):1999\u20132005.","journal-title":"Circ J"},{"issue":"5","key":"1297_CR15","doi-asserted-by":"publisher","first-page":"e008869","DOI":"10.1161\/CIRCINTERVENTIONS.119.008869","volume":"13","author":"H Jinnouchi","year":"2020","unstructured":"Jinnouchi H, Otsuka F, Sato Y, Bhoite RR, Sakamoto A, Torii S, et al. Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study. Circ Cardiovasc Interv. 2020;13(5):e008869.","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"1297_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12928-022-00877-9","volume":"38","author":"H Koiwaya","year":"2023","unstructured":"Koiwaya H, Nishihira K, Kadooka K, Kuriyama N, Shibata Y. Vascular healing in high-bleeding-risk patients at 3-month after everolimus-eluting stent versus biolimus A9-coated stent implantation: insights from analysis of optical coherence tomography and coronary angioscopy. Cardiovasc Interv Ther. 2023;38(1):64\u201374.","journal-title":"Cardiovasc Interv Ther"},{"key":"1297_CR17","doi-asserted-by":"crossref","unstructured":"Nakamura N, Torii S, Aihara K, Noda S, Kato T, Nakazawa K et al. Poor Below the Knee Runoff Impacts Femoropopliteal Stent Failure and Fluoropolymer Antithrombotic Effect in Healthy Swine Model. Eur J Vasc Endovasc Surg. 2023.","DOI":"10.1016\/j.ejvs.2023.07.038"},{"issue":"4","key":"1297_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1583\/14-4721R.1","volume":"21","author":"O Iida","year":"2014","unstructured":"Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, et al. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014;21(4):485\u201392.","journal-title":"J Endovasc Ther"},{"issue":"12","key":"1297_CR19","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1253\/circj.CJ-15-0490","volume":"79","author":"S Torii","year":"2015","unstructured":"Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Murakami T, Natsumeda M, et al. Simultaneous Intravascular Ultrasound Usage Overcomes Misinterpretation When Evaluating Lipid-Rich Plaques With Optical Frequency Domain Imaging\u2013Ex Vivo Study. Circ J. 2015;79(12):2641\u20137.","journal-title":"Circ J"},{"issue":"8","key":"1297_CR20","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1253\/circj.CJ-18-0186","volume":"82","author":"S Kimura","year":"2018","unstructured":"Kimura S, Sugiyama T, Hishikari K, Nakagama S, Nakamura S, Misawa T, et al. Intravascular Ultrasound and Angioscopy Assessment of Coronary Plaque Components in Chronic Totally Occluded Lesions. Circ J. 2018;82(8):2032\u201340.","journal-title":"Circ J"},{"issue":"12","key":"1297_CR21","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.4244\/EIJY15M10_03","volume":"12","author":"S Nakatani","year":"2016","unstructured":"Nakatani S, Sotomi Y, Ishibashi Y, Grundeken MJ, Tateishi H, Tenekecioglu E, et al. Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up. EuroIntervention. 2016;12(12):1498\u2013509.","journal-title":"EuroIntervention"},{"issue":"6","key":"1297_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jvir.2021.02.014","volume":"32","author":"A Sakamoto","year":"2021","unstructured":"Sakamoto A, Torii S, Jinnouchi H, Fuller D, Cornelissen A, Sato Y, et al. Vascular Response of a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) versus a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) in Healthy Swine Femoropopliteal Arteries. J Vasc Interv Radiol. 2021;32(6):792\u2013801. e5.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"1297_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1526602817743747","volume":"25","author":"S Torii","year":"2018","unstructured":"Torii S, Yahagi K, Mori H, Harari E, Romero ME, Kolodgie FD, et al. Safety of Zilver PTX Drug-Eluting Stent Implantation Following Drug-Coated Balloon Dilation in a Healthy Swine Model. J Endovasc Ther. 2018;25(1):118\u201326.","journal-title":"J Endovasc Ther"},{"key":"1297_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ahj.2024.08.003","volume":"277","author":"K Aihara","year":"2024","unstructured":"Aihara K, Torii S, Nakamura N, Hozumi H, Shiozaki M, Sato Y, et al. Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary syndromes. Am Heart J. 2024;277:114\u201324.","journal-title":"Am Heart J"},{"issue":"1","key":"1297_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jvir.2018.07.025","volume":"30","author":"S Torii","year":"2019","unstructured":"Torii S, Jinnouchi H, Sakamoto A, Romero ME, Kolodgie FD, Virmani R, et al. Comparison of Biologic Effect and Particulate Embolization after Femoral Artery Treatment with Three Drug-Coated Balloons in Healthy Swine Model. J Vasc Interv Radiol. 2019;30(1):103\u20139.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01297-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01297-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:04:30Z","timestamp":1781809470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-026-01297-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01297-9","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sho Torii received research grants from Abbot Vascular Japan, Boston Scientific Japan, and Medtronic, and received honoraria from Boston Scientific Japan. Gaku Nakazawa is a consultant for Boston Scientific, Abbott Vascular, Terumo Corp., and Japan Medical Device Technology Co., Ltd, and received research grants from Boston Scientific, Abbott Vascular, Terumo Corp., and Japan Medical Device Technology Co., Ltd. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of funding"}}]}}